Back to search
FDAFDA · Food and drugs·Recall number D-1392-2012

Thyro-Tab 0.050mg., packaged in bulk drums for repackaging. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.

Published July 4, 2012 · Recall initiated: February 3, 2012

Summary

FDA records drug Class II recall D-1392-2012, published July 4, 2012 and initiated February 3, 2012. Recalling firm: Lloyd Inc; Status: Terminated; Reported quantity: 1,924,297 bulk tablets; Lot: Lot HB06311. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Lloyd Inc
Distributor
Nationwide and PR.
Lot
Lot HB06311
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Thyro-Tab 0.050mg., packaged in bulk drums for repackaging. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA. recalled?

Yes. FDA published recall D-1392-2012 on July 4, 2012. Reported hazard: Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit